SUNZEN BIOTECH BHD

KLSE: 0148 (SUNZEN)

Last update: 11 Nov, 5:36PM

0.315

-0.01 (-1.56%)

Previous Close 0.320
Open 0.320
Volume 943,100
Avg. Volume (3M) 910,601
Market Cap 246,316,768
Price / Earnings (TTM) 31.50
Price / Sales 2.95
Price / Book 1.76
52 Weeks Range
0.220 (-30%) — 0.400 (26%)
Profit Margin 6.43%
Operating Margin (TTM) 5.21%
Diluted EPS (TTM) 0.010
Total Debt/Equity (MRQ) 5.11%
Current Ratio (MRQ) 7.14
Operating Cash Flow (TTM) 8.98 M
Return on Assets (TTM) 4.93%
Return on Equity (TTM) 5.98%

Market Trend

Short Term Medium Term
Industry Packaged Foods (MY) Bullish Bullish
Packaged Foods (Global) Mixed Mixed
Stock SUNZEN - -

Stockmoo Score

1.4
Analyst Consensus 2.0
Insider Activity NA
Price Volatility 2.0
Technical Moving Averages 2.5
Technical Oscillators -1.0
Average 1.38

Similar Stocks

Stock Market Cap DY P/E P/B
SUNZEN 246 M - 31.50 1.76
DLADY 2 B 1.61% 22.46 4.11
HUPSENG 944 M 3.42% 16.71 5.35
AJI 912 M 16.69% 2.24 1.14
KAWAN 588 M 2.50% 18.67 1.48
SDS 475 M 1.47% 12.89 3.45

Sunzen Biotech Bhd is engaged in the business of research and development of biotechnology and manufacturing and marketing of animal health products. The company operates in the business segments of Manufacturing and trading animal health products; Trading and processing of crude palm oil and related products; Traditional Chinese medicines and herbal health foods and beverages and loan financing. It generates key revenue from the Traditional Chinese medicines and herbal health foods and beverages segment.

Sector Consumer Defensive
Industry Packaged Foods
Investment Style Small Core
% Held by Insiders 55.84%

No data within this time range.

No data within this time range.

Date Type Details
19 Nov 2024 Announcement Additional Listing Announcement /Subdivision of Shares
08 Nov 2024 Announcement Additional Listing Announcement /Subdivision of Shares
01 Nov 2024 Announcement Additional Listing Announcement /Subdivision of Shares
30 Oct 2024 Announcement Annual Report & CG Report - 2024
30 Oct 2024 Announcement Part A: Share Buy-Back Statement in relation to the Proposed Renewal of Authority for Purchase of Own Shares by the Company Part B: Circular to Shareholders in relation to the Proposed Change of Company Name from "Sunzen Biotech Berhad" to "Sunzen Group Berhad"
29 Oct 2024 Announcement General Meetings: Notice of Meeting
28 Oct 2024 Announcement Additional Listing Announcement /Subdivision of Shares
22 Oct 2024 Announcement Notice of Person Ceasing (Section 139 of CA 2016) - MADAM CHUM MUN CUAN
22 Oct 2024 Announcement Additional Listing Announcement /Subdivision of Shares
21 Oct 2024 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
21 Oct 2024 Announcement Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MR TEO YEK MING
21 Oct 2024 Announcement Changes in Director's Interest (Section 219 of CA 2016) - MR TEO YEK MING
17 Oct 2024 Announcement Additional Listing Announcement /Subdivision of Shares
14 Oct 2024 Announcement SUNZEN BIOTECH BERHAD ("SUNZEN" OR "THE COMPANY") - PROPOSED RENEWAL OF AUTHORITY FOR PURCHASE OF OWN SHARES BY THE COMPANY ("THE PROPOSED RENEWAL OF SHARE BUY-BACK AUTHORITY")
14 Oct 2024 Announcement Change of Company Name - SUNZEN GROUP BERHAD
11 Oct 2024 Announcement TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : NON RELATED PARTY TRANSACTIONS
11 Oct 2024 Announcement Additional Listing Announcement /Subdivision of Shares
10 Oct 2024 Announcement Additional Listing Announcement /Subdivision of Shares
09 Oct 2024 Announcement PROVISION OF FINANCIAL ASSISTANCE
04 Oct 2024 Announcement Additional Listing Announcement /Subdivision of Shares
02 Oct 2024 Announcement Additional Listing Announcement /Subdivision of Shares
02 Oct 2024 TheEdge Sunzen Biotech identifies another target for acquisition, deal may be reached next year
01 Oct 2024 Announcement TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : NON RELATED PARTY TRANSACTIONS
01 Oct 2024 TheEdge MISC, MHB, PA Resources, Tanco, Ho Hup, Central Global, Sunzen Biotech, Aemulus, Pharmaniaga, Plenitude, Pasdec
30 Sep 2024 Announcement TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : NON RELATED PARTY TRANSACTIONS
24 Sep 2024 Announcement Article Entitled: "Sunzen Biotech aims to sell assets"
20 Sep 2024 TheEdge Sunzen Biotech eyes double-digit growth on rising demand for bird's nest products, loan financing
20 Sep 2024 Announcement General Meetings: Outcome of Meeting
19 Sep 2024 Announcement Notice of SBB by a Company Pursuant to Section 127 (16) of CA 2016
12 Sep 2024 Announcement Immediate Announcement on Shares Buy Back
06 Sep 2024 Announcement Additional Listing Announcement /Subdivision of Shares
05 Sep 2024 Announcement CIRCULAR TO SHAREHOLDERS OF SUNZEN BIOTECH BERHAD ("SUNZEN") IN RELATION TO THE PROPOSED ACQUISITIONS OF THE REMAINING 30% EQUITY INTEREST IN: (I) ECOLITE BIOTECH MANUFACTURING SDN BHD ("ECOLITE"), A 70%-OWNED SUBSIDIARY OF SUNZEN, FOR A PURCHASE CONSIDERATION OF RM15.00 MILLION; AND (II) YANMING RESOURCES SDN BHD, A 70%-OWNED SUBSIDIARY OF ECOLITE, FOR A PURCHASE CONSIDERATION OF RM4.50 MILLION, TO BE SATISFIED ENTIRELY BY THE ISSUANCE OF 66,101,694 NEW SUNZEN SHARES
04 Sep 2024 Announcement General Meetings: Notice of Meeting
29 Aug 2024 Announcement TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : NON RELATED PARTY TRANSACTIONS
29 Aug 2024 Announcement - REVALUATION OF NON-CURRENT ASSETS
29 Aug 2024 Announcement PROVISION OF FINANCIAL ASSISTANCE
29 Aug 2024 Announcement Consolidated results for the financial period ended 30/06/2024
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2024 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria